Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study evaluating mosunetuzumab plus lenalidomide in follicular lymphoma, and comparison of subcutaneous versus intravenous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• LUNSUMIO (mosunetuzumab)
• Revlimid (lenalidomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Follicular Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING